AstraZeneca recognizes Sumspring Three Springs Stone

AstraZeneca is an innovation driven biopharmaceutical company with a total revenue of $44.4 billion in 2022. It was formed in 1999 by the merger of the former Swedish company AstraZeneca and the former British company Jelicon. We have been operating in China for 30 years. In addition to having production bases in Wuxi and Taizhou, we also have a research and development center in Shanghai.

Container sealing integrity testing is currently a testing project that domestic pharmaceutical companies are more concerned about, and as a pharmaceutical company AstraZeneca, it was even earlier focused on. After rigorous testing and market research, AstraZeneca chose the Sumspring Three Springs Stone Sealing Testing Equipment. AstraZeneca staff also stated that Sumspring Sanquan Zhongshi is one of their few domestic instrument suppliers.

As a domestic pharmaceutical packaging material testing instrument, Sumspring Sanquan Zhongshi's years of technological innovation and excellent service quality have been recognized by international pharmaceutical company AstraZeneca. This is another affirmation of Sumspring's stone strength in the Three Springs. We will also continue to work hard and strive to provide more high-quality testing instruments and services for more pharmaceutical companies, safeguarding the quality of drugs!